COO insider trading
NasdaqGS HealthcareCOOPER COMPANIES, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About COOPER COMPANIES, INC.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Company website: www.coopercos.com
COO insider activity at a glance
FilingIQ has scored 1,237 insider transactions for COO since Jan 8, 2015. The most recent filing in our index is dated Apr 1, 2026.
Across the full history, 18 open-market purchases
and 209 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on COO insider trades is 60.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest COO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding COO
Frequently asked
- How many insider trades does FilingIQ track for COO?
- FilingIQ tracks 1,237 Form 4 insider transactions for COO (COOPER COMPANIES, INC.), covering filings from Jan 8, 2015 onwards. 24 of those were filed in the last 90 days.
- Are COO insiders net buyers or net sellers?
- Across the full Form 4 history for COO, 18 transactions (1%) were open-market purchases and 209 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does COO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is COO in?
- COOPER COMPANIES, INC. (COO) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $16.71B.
Methodology & sources
Every COO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.